Stay updated on Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Sign up to get notified when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.

Latest updates to the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedTaoyuan, Taiwan, 333 was replaced with Taoyuan City, Taiwan, 333 in the locations section, clarifying the city designation for that site.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a newer version of the page content. This update reflects a version-control change rather than a modification to the study data shown.SummaryDifference0.0%

- Check26 days agoChange DetectedAdded references under related topics (including Ovarian cancer / MedlinePlus Genetics) and updated the displayed site revision version. Removed an older revision label (Revision: v3.5.0), with the page now showing Revision: v3.5.2.SummaryDifference0.1%

- Check33 days agoChange DetectedRemoved the related topics 'Ovarian cancer' and 'MedlinePlus Genetics' from the related topics section.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded related topics links for Ovarian cancer and MedlinePlus Genetics on the study page.SummaryDifference0.0%

- Check48 days agoChange DetectedRemoved the 'Ovarian cancer' condition tag and the related topic 'MedlinePlus Genetics' from the page, reducing visible context and linked related information.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.